secwatch.observer — SEC 8-K summary
======================================

Issuer:     KORU Medical Systems, Inc. (KRMD)
CIK:        0000704440
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001161697-25-000050
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KORU Medical reports record Q4 revenue $8.9M (+23% YoY); positive cash flow in Q4
--------------------------------------------------------------------------------

- Preliminary full-year 2024 net revenue of $33.7M, up 18% YoY; Q4 revenue $8.9M, up 23% YoY.
- Ending cash balance $9.6M; Q4 generated positive cash flow of $0.8M.
- Full-year cash burn $1.9M, a 67% improvement over prior year.
- CEO cites U.S. market share gains, international expansion, and progress on new drug therapy labeling.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/704440/000116169725000050/0001161697-25-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/704440/000116169725000050/form_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001161697-25-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer